Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy

Citations Over TimeTop 12% of 2021 papers

Abstract

Mitochondrial encephalomyopathies are disorders caused by mitochondrial and nuclear DNA mutations which affect the nervous and muscular systems. Current therapies for mitochondrial encephalomyopathies are inadequate and mostly palliative. However, stem cell-derived mitochondria transplantation has been demonstrated to play an key part in metabolic rescue, which offers great promise for mitochondrial encephalomyopathies. Here, we summarize the present status of stem cell therapy for mitochondrial encephalomyopathy and discuss mitochondrial transfer routes and the protection mechanisms of stem cells. We also identify and summarize future perspectives and challenges for the treatment of these intractable disorders based on the concept of mitochondrial transfer from stem cells.

Related Papers

• 99mTc-HMPAO brain single photon emission computerized tomography in mitochondrial encephalomyopathies.(1995)
• MR demonstration of leukoencephalopathy associated with mitochondrial encephalomyopathy: case report.(1991)
• [Mitochondrial function and mitochondrial DNA in a series of 64 patients suspected of having mitochondrial myopathy].(1991)
• The clinical analysis of mitochondrial myopathy and mitochondrial encephalomyopathy(2008)
• [Mitochondrial myopathy and mitochondrial encephalomyopathy].(2002)